微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 12.49% | -12.96% | 61.58% | 4/51 | 3.32% | 澳洋健康 | 34.16% | 行业排名> |
| 2024-06-30 | 7.73% | -8.63% | 73.71% | 5/51 | 2.09% | 澳洋健康 | 30.56% | 行业排名> |
| 2024-03-31 | 4.45% | -10.64% | -67.09% | 4/51 | 1.19% | 澳洋健康 | 28.14% | 行业排名> |
| 2023-12-31 | 13.52% | -19.67% | -5.78% | 6/51 | 3.73% | 澳洋健康 | 39.54% | 行业排名> |
| 2023-09-30 | 14.35% | -12.61% | 69.62% | 6/51 | 6.82% | 澳洋健康 | 61.84% | 行业排名> |
| 2023-06-30 | 8.46% | -10.48% | 69.88% | 9/51 | 1.93% | 澳洋健康 | 48.34% | 行业排名> |
| 2023-03-31 | 4.98% | -11.39% | -70.41% | 5/51 | 2.58% | 澳洋健康 | 58.19% | 行业排名> |
| 2022-12-31 | 16.83% | -36.9% | 2.5% | 14/51 | -0.62% | *ST宜康 | 75.53% | 行业排名> |
| 2022-09-30 | 16.42% | -34.87% | 73.76% | 13/51 | 11.4% | 博腾股份 | 39.77% | 行业排名> |
| 2022-06-30 | 9.45% | -35.67% | 68.15% | 14/51 | 5.56% | 睿智医药 | 41.16% | 行业排名> |
| 2022-03-31 | 5.62% | -23.74% | -78.93% | 8/51 | 3.14% | 澳洋健康 | 51.68% | 行业排名> |
| 2021-12-31 | 26.67% | 13.2% | 5.79% | 5/51 | -6.68% | 澳洋健康 | 40.93% | 行业排名> |
| 2021-09-30 | 25.21% | 25.86% | 71.61% | 2/51 | 2.3% | 金域医学 | 43.58% | 行业排名> |
| 2021-06-30 | 14.69% | 99.86% | 99.32% | 7/51 | 2.28% | 金域医学 | 35.41% | 行业排名> |
| 2021-03-31 | 7.37% | 788.79% | -68.72% | 5/51 | 1.79% | 阳光诺和 | 26.2% | 行业排名> |
| 2020-12-31 | 23.56% | -19.4% | 17.62% | 13/51 | 10.95% | 金域医学 | 13.23% | 行业排名> |
| 2020-09-30 | 20.03% | -24.07% | 172.52% | 6/51 | 7.83% | 万邦医药 | 52.05% | 行业排名> |
| 2020-06-30 | 7.35% | -48.85% | 786.92% | 11/51 | 2.48% | 华大基因 | 48.52% | 行业排名> |
| 2020-03-31 | -1.07% | -115.4% | -103.66% | 24/51 | -0.22% | 华大基因 | 31.24% | 行业排名> |
| 2019-12-31 | 29.23% | 4.92% | 10.8% | 7/51 | 65.31% | 阳光诺和 | 13.99% | 行业排名> |
| 2019-09-30 | 26.38% | 8.25% | 83.58% | 2/51 | 10.68% | 南华生物 | 2848.07% | 行业排名> |
| 2019-06-30 | 14.37% | 14.96% | 106.76% | 2/51 | 5.65% | 南华生物 | 98.98% | 行业排名> |
| 2019-03-31 | 6.95% | 15.45% | -75.05% | 3/51 | 3.54% | 南华生物 | 82.46% | 行业排名> |
| 2018-12-31 | 27.86% | 21.18% | 14.32% | 7/51 | -0.6% | 南华生物 | 48.41% | 行业排名> |
| 2018-09-30 | 24.37% | 21.67% | 94.96% | 2/51 | 2.62% | 万邦医药 | 106.72% | 行业排名> |
| 2018-06-30 | 12.5% | 23.27% | 107.64% | 2/51 | 1.51% | 国际医学 | 46.66% | 行业排名> |
| 2018-03-31 | 6.02% | 18.04% | -73.81% | 1/51 | 0.52% | 普蕊斯 | 22.99% | 行业排名> |
| 2017-12-31 | 22.99% | 29.96% | 14.78% | 3/51 | 1.73% | 通策医疗 | 6.02% | 行业排名> |
| 2017-09-30 | 20.03% | 18.73% | 97.53% | 2/51 | 8.61% | 普蕊斯 | 58.68% | 行业排名> |
| 2017-06-30 | 10.14% | 3.68% | 98.82% | 6/51 | 60.47% | 爱尔眼科 | 20.87% | 行业排名> |
| 2017-03-31 | 5.1% | -0.58% | -71.17% | 2/51 | -5.59% | 南华生物 | 1666.98% | 行业排名> |
| 2016-12-31 | 17.69% | -0.17% | 4.86% | 13/51 | 23.06% | 爱尔眼科 | 5.19% | 行业排名> |
| 2016-09-30 | 16.87% | -4.8% | 72.49% | 5/51 | 5.93% | 南华生物 | 383.03% | 行业排名> |
| 2016-06-30 | 9.78% | 1.03% | 90.64% | 6/51 | 4.57% | *ST宜康 | 36.84% | 行业排名> |
| 2016-03-31 | 5.13% | 5.34% | -71.05% | 2/51 | 1.51% | 药石科技 | 24.53% | 行业排名> |
| 2015-12-31 | 17.72% | 1.96% | 0% | 10/51 | 22.23% | 南华生物 | 55.01% | 行业排名> |
| 2015-09-30 | 17.72% | 10.13% | 83.06% | 2/51 | 5.27% | *ST宜康 | 36.74% | 行业排名> |
| 2015-06-30 | 9.68% | 21.3% | 98.77% | 3/51 | -30.81% | 南华生物 | 24.73% | 行业排名> |
| 2015-03-31 | 4.87% | 4.06% | -71.98% | 3/51 | -5.77% | 南华生物 | 400.84% | 行业排名> |